Analyze, Identify, and Improve Metadata in Minutes, Not Months

Analyze, Identify, and Improve Metadata in Minutes, Not Months

Regulated industries generate enormous volumes of documentation every year. Regulatory submissions, clinical reports, quality documentation, and scientific studies all contribute to a quickly expanding library of critical information. An essential part of that information is the document metadata, the structure that allows documents to be categorized, understood, and retrieved in context.

Unfortunately, as a company grows and matures, data silos get moved, updated, and combined, causing metadata to be disconnected from the documents and directories. Staff and process changes, archiving initiatives, garbled translations, or system improvements can all erode the quality, accuracy, and reliability of critical information.

What started as a well-organized repository slowly becomes something much harder to trust.

The Problem You Don’t See Until It’s A Big Problem

The depth of the disconnects are often not fully realized until the organization decides to consolidate or migrate their repositories to a modern technology solution. What was assumed to be ‘migration ready data’ is discovered to be:

    • Incomplete and inconsistent due to years evolving standards and interpretations
    • Structured in ways that are incompatible with modern platforms
    • Missing information that is required by new regulatory requirements
    • Complicated by legacy content from mergers, acquisitions, or past migrations

Finding and fixing these issues manually requires reviewing thousands, or even millions of documents. It demands skilled internal resources, consumes valuable time, and often puts critical projects at risk.

For teams already operating under tight timelines, this effort can increase costs, delay migrations, and divert focus from higher-value work.

A New Approach to Metadata Recovery

Recent advances in artificial intelligence (AI) and natural language processing (NLP) are transforming how organizations approach metadata remediation. Rather than relying on manual review, AI-powered tools promise to analyze documents at scale, identify patterns, and extract metadata directly from the content itself. This process transforms unstructured documents into searchable and structured information assets recovering valuable information that was previously hidden inside document libraries.

But there’s a catch.
The majority of AI and NLP models were built and trained on generic datasets, not on highly-specialized, regulated content. Without domain expertise, they can do part of the job, but there’s no way to be sure the information is accurate, consistent, and compliant. This often leads to additional validation effort, delays, and uncertainty, undermining the very efficiency gains AI promises to deliver.

There’s a better way.

Proven AI and NLP-Powered Analysis with fme’s MetadataAssist

For over 25 years fme has been helping the largest firms in regulated industries migrate their repositories of complex regulated data and documents into, out of, and between the most powerful content management platforms from OpenText, Hyland, Veeva, Microsoft, and more.

With this experience and knowledge, we developed MetadataAssist™, a solution specifically built to address the challenges of highly regulated environments. Built on insights gained from thousands of hours of fme migration projects, we trained our advanced artificial intelligence (AI) and natural language processing (NLP) tools to analyze and classify large volumes of highly regulated content ensuring complete accuracy, consistency, and regulatory compliance.  

fme MetadataAssist simplifies and accelerates the analysis, identification, categorization, and updating of metadata across millions of documents, completing in minutes what traditionally takes teams weeks or months.

MetadataAssist automatically examines:

    • Document metadata
    • File content
    • Folder and location structures
    • Context within documents

In a pharmaceutical environment, the solution can analyze documents across multiple formats and languages, identifying and extracting critical metadata such as:

    • Product name
    • Dosage strength
    • Dosage form
    • Regulatory identifiers
    • Scientific and contextual data

This is far beyond the basic extraction process of other generic solutions. MetadataAssist’s NLP technology interprets the context surrounding the metadata, allowing the system to understand how documents should be classified based on their content, purpose, and relevance. This industry-trained contextual understanding ensures more accurate classification and improved document usability across enterprise systems.

The result is a well-organized, accessible document library where content can be properly classified, easily searched, and efficiently managed within your CMS or migrated into a new repository or platform.

See fme’s MetadataAssist in Action

Whether you are streamlining your current environment or planning a larger platform consolidation or migration initiative, MetadataAssist can transform complex, disconnected content into structured, searchable, and regulatory compliant information.

To learn how fme MetadataAssist can transform your document repositories, download the datasheet below, and then contact us to schedule a demo and experience the power and flexibility of industry-trained and AI-driven metadata classification.

Join fme at the Pharmaceutical Manufacturing World Summit

Join fme at the Pharmaceutical Manufacturing World Summit

Every year, the Pharmaceutical Manufacturing World Summit in Boston brings together industry leaders, innovators, and manufacturing experts to explore the future of pharmaceutical production. As both attendees and sponsors, the fme team enjoys this unique opportunity to engage in meaningful conversations, exchange insights, and advise on the technology and data management strategies that shape Life Sciences manufacturing today. Many of the key themes that defined last year’s agenda continue to be critical topics within the industry.

Key Themes Shaping Pharmaceutical Manufacturing World Summit

Year after year, one common thread unifies the agenda: Data is the foundation of transformation for business success.

Whether enabling AI, supporting regulatory compliance, or driving operational efficiency, success depends on having trusted, structured, and accessible data across the product lifecycle. Here are some of the recent areas of focus we’ve repeatedly shared with our clients:

ECM Platform ServicesData as a Strategic Asset

One of the most important points of the conference is data is no longer just operational, it’s transformational. Organizations are increasingly relying on high-quality, accessible data to drive decision-making across supply chains, manufacturing performance, and patient safety.

The ability to treat data as a strategic asset rather than a byproduct has finally been recognized as a competitive differentiator, and has been fme’s focus and mission for over 25 years. We help companies maximize the value and power of their data, ensuring it is structured, reusable, and ready to migrate into powerful solutions that unlock its full value across the enterprise.

digital_infrastructure

Navigating Geopolitical Uncertainty

Global manufacturing strategies are being reshaped by shifting regulatory landscapes, trade policies, and geopolitical tensions. From increased pressure to localize production in the U.S. to evolving FDA leadership and AI regulation, companies are operating in an environment of heightened uncertainty and risk.

fme helps guide organizations through the dynamic data management challenges that can affect supply chain resilience, inspection readiness, and compliance strategies.

Infrastructure Investment and Digital Transformation

The scale of investment in modern manufacturing infrastructure is staggering. Leading pharmaceutical companies are building digitally native, highly automated facilities designed for flexibility, speed, and advanced modalities like cell and gene therapies.

Technologies such as digital twins, robotics, IIoT, and integrated MES/QMS platforms are becoming foundational. At the same time, organizations are recognizing that less than 1% of process data is often fully utilized, highlighting a major opportunity for transformation.

To ensure technology investments address both immediate and long-term needs, it is critical to work with a technology partner that understands the technical and business goals of an integrated research, development, and manufacturing pipeline.

Pricing Pressures Driving Efficiency

With rising costs across the industry, manufacturers are under pressure to do more with less. The focus has shifted toward reducing inefficiencies, eliminating rework, and accelerating system consolidation.

This is where digital enablement and automation powered by clean, high-integrity data are playing a critical role in turning compliance into a value-generating function rather than a cost center.

Innovation Accelerating at Scale

From AI-driven quality transformation to novel manufacturing platforms, innovation is rapidly reshaping the industry.

Highlights from last year included:

  • AI-enabled quality systems and predictive manufacturing
  • Expansion into advanced modalities like ADCs and cell therapies
  • End-to-end digital supply chain orchestration
  • Increasing use of GenAI to enhance quality and operational efficiency

Organizations are not just experimenting. They are scaling these innovations to drive measurable business outcomes before their competition.

Join Us at This Year’s Summit

We’re excited to return to the Pharmaceutical Manufacturing World Summit this year as a sponsor and continue the conversation with industry leaders.

If you’ll be attending, we’d love to connect! Contact us and we’ll schedule a time to discuss your current challenges, share our proven strategies and insights, or explore how to accelerate your digital and data initiatives. If you can’t attend and would like a summary of the essential topics and sessions, let us know.

DIA RSIDM 2026 Hot Topic: Data Quality Transformation

DIA RSIDM 2026 Hot Topic: Data Quality Transformation

An annual staple of the regulatory industry, DIA’s RSIDM brings together industry and regulatory stakeholders to discuss evolving data standards, requirements and effective data management strategies. This year, fme’s regulatory experts David Gwyn, Frank D’Entrone and Scott Coles will be attending and answering questions in Booth #116. Stop by and see us! We’d love to discuss your challenges and plans for 2026, and share our proven solutions for managing complex regulatory submissions.

The Real Story: Data Quality Transformation

As data migration experts for the Life Sciences industry, we’ve helped the world’s largest organizations move complex regulatory ecosystems into platforms and solutions that align with their business processes and goals. Through our experiences, we’ve also realized that the actual migration is only one chapter of a much larger story.

In fact, the most urgent and impactful challenges our clients face aren’t about switching platforms. They’re about the quality, readiness, governance, and trustworthiness of the data they already have. And according to our clients, that’s where fme shines far brighter than other providers and especially the newest ‘intelligent’ solutions.

We Are Data Quality Transformation Specialists

fme understands the organization and structure of a client’s data is a reflection of the meaning, use and purpose of the information embedded within. Data, metadata and content all add essential context to data, and each detail needs to be available to realize its full value.

This is why clients come to us; they recognize fme’s experts can evaluate and enrich their data before incorporating it into their technology platform and business processes. Whether it’s organizing legacy content, remediating years of inconsistent metadata, strengthening governance practices, or establishing stewardship models that scale across global regulatory teams, fme knows where to look, and how to ensure every element is structured for efficient and contextual use.

This is the work we’re doing right now—multi-million-dollar data readiness and remediation initiatives—with some of the world’s largest and most complex Life Sciences companies. These aren’t migration projects. They’re data projects that emphasize critical concepts:

  • Data readiness is the foundation for modernization and digital transformation.
  • Governance and stewardship drive regulatory confidence.
  • Quality transformation unlocks efficiency, compliance, and innovation.

And they reflect a reality that’s becoming impossible to ignore:
You don’t have to move to a new platform to improve. You just need better data.

Understand Where You Are First

This has been one of the biggest expansions in the strategies we use to serve our clients. A transformation doesn’t start with technology change. It starts with understanding your current state, and building the pathway to allow your data to power your business goals.

fme’s solutions like MetadataAssist℠ and HealthCheckAssist℠ are strategically designed to provide regulatory and RIM teams with a fast, structured way to evaluate:

  • What data exists
  • How clean or accurate it is
  • How well metadata models are applied
  • Where governance gaps are limiting efficiency
  • What improvements can be made without moving platforms

In many cases, clients discover that a migration is unnecessary, or at least not urgent. By improving their data quality and governance practices, they can dramatically increase the value of the systems they already use.

To Migrate or Not: Choosing What’s Next

Of course, some organizations ultimately decide that their current platform can’t support where they want their business to go. When that happens, we help them choose their next solution with clear quantitative and qualitative data to cut through the marketing jargon and seller-lingo that can obfuscate true capabilities and benefits.

SelectAssist℠ is a unique offering that pairs our regulatory experts with client stakeholders to guide them through detailed platform evaluations and selection based on:

  • Regulatory workflows
  • Data and metadata requirements
  • Change readiness
  • Long-term scalability
  • Integration and interoperability needs

It’s important to clarify that while fme has many platform partners, our goal is to guide clients to the best solution for their unique goals. We provide a holistic, data-justified perspective focused on their needs, not a quarterly sales quota.

When Migration Is the Answer, We Deliver with Precision

When the data is optimized, technology is selected, and the organization is ready to move platforms, fme’s 30 years of migration experience come into play. We have unmatched knowledge, proven methodologies and acceleration toolsets to execute seamless regulatory content and data migrations at scale most service providers have never touched.

We combine:

  • AI-driven automation
  • Proven methodologies
  • Industry-leading tools
  • Deep regulatory and compliance expertise

After hundreds of successful migration projects, we have the skill and knowledge to deliver a seamless, accurate, and validated transition first time, every time.

Learn More about Data Quality Transformation

fme is evolving along with our clients’ needs. The industry is hungry for organizations that understand not just platforms, but the data that fuels regulatory compliance, submission quality, operational efficiency, and innovation.

So when we say we’re data quality transformation specialists, we mean:

  • We assess.
  • We remediate.
  • We govern.
  • We steward.
  • We prepare for the future.
  • And yes, when it’s the right time, we migrate.

But the story always starts with data quality. Do you REALLY know yours?

If you want to understand the value your data could be delivering, or if you’re struggling to achieve efficiency and compliance with the information you already have, we’re here to help you make it happen. Download the resource below to learn more.

Webinar 🖥️ Merger-Ready RIM with TransferAssist℠

Webinar 🖥️ Merger-Ready RIM with TransferAssist℠

Today’s multi-million and billion dollar Life Sciences mergers and acquisitions rarely come with breathing room after the ink dries. From the moment a deal closes, IT and business leaders are expected to migrate and integrate data and systems without interrupting compliance, and often with limited forewarning or visibility into what they’ve acquired.

The risks of getting it wrong are real: missed deadlines, regulatory and compliance violations, frustrated users, operational drag and potential millions in lost value.

TransferAssist℠: A Unique Solution for AM&D Integrations

fme has helped several of our clients through these challenges, and realized the industry needed a proven, scalable, automation-powered solution that eliminates the friction and accelerates the acquisition, merger and divestiture process.

We also recognized that while M&A initiatives are generally independent projects, most firms will go through several AM&D cycles, often within a few years depending on economic and industry business conditions. Any solution would need to be standardized and repeatable, building a solid foundation and framework that would further accelerate each subsequent event.

With these common issues in mind, fme created TransferAssist℠, a comprehensive solution that simplifies the AM&D data consolidation/separation process from initial due diligence and system evaluation through final integration and go-live.

Learn More In Our Webinar Recording

On Thursday, September 18th fme presented Merger Ready RIM: Building Confidence in Every AM&D Transition with our associates at TOPRA, The Organization for Regulatory Professionals in Regulatory Affairs. In this session we shared details on how you can shift from project-based chaos to programmatic control using the proven, structured methodology of TransferAssist. We’d love to get your perspective and answer any questions you have about how to simplify AM&D data transitions.

Why View This Webinar?

In this session, you’ll learn:

    • The most frequent regulatory challenges during AM&D initiatives.
    • Proven short-term tactics to reduce risk and maintain compliance.
    • Long-term strategies to standardize, accelerate, and strengthen your regulatory data model.

You’ll also learn how TransferAssist helps Life Sciences companies:

    • Build a repeatable, scalable process for acquisitions and divestitures
    • Accelerate integrations with automation and AI
    • Maintain regulatory compliance and data quality throughout the process
    • Reduce IT burden while ensuring business continuity and user adoption

Webinar Details

Title: Merger Ready RIM: Building Confidence in Every AM&D Transition

Date: Recorded Thursday, September 18, 2025

 

Who Should View?

    • Senior Managers, Directors, and VPs responsible for IT, Regulatory Affairs, Quality, and Operations
    • M&A program leaders looking to reduce complexity and risk in their integration strategy
    • Business and technology leaders tasked with ensuring compliance and business continuity in high-stakes transitions

If your growth strategy depends on acquisitions or divestitures, you can’t afford to improvise. With TransferAssist, you’ll gain a future-proof framework to manage the data and content complexities of AM&D before, during, and after the deal.

How to Master Merger & Acquisition Data Integration

How to Master Merger & Acquisition Data Integration

fme supports some of the world’s most ambitious acquisition strategies, often under tight timelines, with minimal visibility into the acquired company’s systems, and urgent demands to “make it all work” from day one.

The reality? Most M&A activities start in a rush and stay there. IT and business teams are expected to absorb new entities, migrate content, manage compliance, and sunset legacy platforms, all while trying to maintain continuity and meet regulatory obligations. And they’re expected to do it repeatedly.

Why TransferAssist?

M&A success depends on how quickly and reliably you can bring newly acquired teams, systems, and data into your enterprise technology stack, or, in the case of divestitures, cleanly separate and transfer it. Delays, inconsistencies, or missteps can cost millions in regulatory risk, operational drag, or lost productivity.

fme created TransferAssist to eliminate the friction that typically slows down acquisition and divestiture integration. It delivers a scalable, automation-powered framework that empowers organizations to migrate, separate, or integrate data with speed, confidence, and compliance. Whether you’re evaluating a deal, in the thick of integration, or planning a strategic carve-out, TransferAssist meets you where you are: simplifying, accelerating, and standardizing every step of the process.

The Four-Phase TransferAssist Approach

Whether you’re acquiring three companies a year or ten, TransferAssist helps you shift from project-based chaos to programmatic control. Here’s how:

Phase 1: Foundation & Readiness

This phase establishes your strategic backbone for repeatable M&A success.

  • Build a unified, extensible data model and pipeline to receive and integrate new information.
  • Define archiving, retention, and migration rules to ensure consistency and compliance.
  • Run fme-driven, independent pre-deal assessments to identify data risks and gaps before legal close.
  • Leverage standard governance models and prebuilt templates for accelerated onboarding.

The bonus? Even before the acquisition is finalized, TransferAssist allows you to evaluate the technical landscape of a target company without exposing sensitive data or compromising confidentiality.

Phase 2: Execution & Automation

Now it’s time to move fast, without sacrificing quality.

  • Deploy pre-validated migration playbooks and accelerators to reduce setup time.
  • Enable 24/5 global execution coverage via fme teams in North America, Romania, and India.
  • Automate classification and verification with AI-powered workflows.
  • Monitor and iterate using built-in feedback loops and structured improvement cycles.

The result? Faster, more predictable migrations with fewer human errors and more visibility.

Phase 3: User Enablement & Business Continuity

Technology is only half the battle, people and processes matter too.

  • Align go-live plans with training and change management strategies.
  • Partner with your system integrator to onboard users to the right platforms.
  • Reduce dual-system overhead and accelerate decommissioning of legacy tools.
  • Measure ROI with KPIs like time-to-productivity, user adoption, and operational savings.

Key insight? Happy, empowered users are the fastest path to post-acquisition value.

Phase 4: Optimization & Scalability

Turn repeatability into strategic advantage.

  • Transition to a frictionless integration model for future acquisitions.
  • Reduce burden on internal IT and business teams.
  • Drive continuous improvement with a closed-loop optimization model.
  • Seamlessly scale the framework for both large and small acquisition targets.

The payoff? You’re not just executing integrations, you’re building a resilient, acquisition-ready enterprise.

Ready to Future-Proof Your Merger & Acquisition Strategy?

If your organization’s growth strategy hinges on acquisitions or divestitures, it’s time to stop improvising. With TransferAssist, fme offers a future-proof, plug-and-play framework to manage the data and content complexities of any M&A&D initiative, before, during, and long after the deal closes.

Whether you’re navigating your first large-scale divestiture or streamlining your tenth acquisition of the year, TransferAssist ensures every transition adds value, not risk.

Download this datasheet to learn more about fme’s TransferAssist.

For even more details on how TransferAssist solves AM&D challenges, be sure to reqest our webinar with TOPRA, The Organization for Professionals in Regulatory Affairs. In this session we discuss the unique regulatory challenges and risks in AM&D initiatives, and how to establish a solid and secure foundation for today and the future.

Webinar 🖥️ Merger-Ready RIM with TransferAssist℠

View the webinar now >>

 

Authors

David Gwyn, VP Strategy and Solutions, fme Life Sciences

David Gwyn is a strategic, creative, and data-driven Business Development and Technology Specialist with extensive expertise in building key partnerships, implementing business strategies, and deploying solutions across the life science and emerging technology industries. For the past 30 years, he has led teams in the delivery of content management, clinical, and quality solutions with a recent focus on end-to-end Regulatory Information Management (RIM). His practice has evolved in parallel to the Life Sciences industry, moving from custom-developed software solutions to packaged-based implementations, and the development of methodologies and best practices to guide practitioners in realizing the greatest return on investment. Mr. Gwyn is passionate about helping organizations evolve from traditional to digital businesses and increase their ability to act with speed and agility.

Meghan Carr, VP Commercial Operations, fme Life Sciences

With over 18 years of experience in the life sciences industry, Meghan is a proven leader in solving complex IT challenges and delivering effective services and solutions on a global scale. Her experience with firms like Veeva and Sparta System (now Honeywell) has helped Meghan become adept at guiding technology-enabled business across the life sciences industry, from leading pharmaceutical and medical device organizations to nutraceuticals and cosmetics. Her talent at understanding the business goals and process requirements of her clients combined with her vast technology and business experience empower her skill at defining comprehensive solutions that serve today’s needs while preparing for tomorrow’s possibilities.

Navigating QMS Modernization: Choose the Right Solution and Partner

Navigating QMS Modernization: Choose the Right Solution and Partner

The Hidden Challenges of QMS/QDMS Selection

For life sciences organizations, quality is more than a department; it is the foundation of regulatory compliance, patient safety, and operational excellence. Yet as the industry evolves, many companies still rely on legacy Quality Management Systems (QMS) and Quality Document Management Systems (QDMS) that were designed for an earlier, less connected era.

Selecting a modern QMS/QDMS that can meet today’s requirements and provide a foundation for future needs is no simple task. The complexity of life sciences processes, the volume and criticality of regulated documentation, and the need for seamless integration with enterprise systems all make QMS/QDMS selection a uniquely challenging initiative.

And the risks are high. A well-chosen, well-implemented system can become a driver of operational agility, proactive quality management, and competitive advantage. A poorly chosen solution can result in low adoption, compliance gaps, inefficiencies, and missed business goals.

Common Pitfalls on the QMS Modernization Journey

Life sciences companies face common obstacles when selecting and migrating to new QMS/QDMS solutions:

Disconnected Systems and Data Silos

Many organizations have separate systems for document control, training, CAPA, audit management, and more resulting in manual workarounds, inconsistent data, and increased compliance risk.

Inconsistent Data, Metadata and Document Quality

Years of unstructured, inconsistent, or duplicate records can undermine data integrity. Without efficient analysis, categorization, and verification of data and documents, a migration could sustain previous quality issues in the new solution instead of resolving them.

Legacy Integrations and Customizations

QMS platforms must connect with ERP, MES, regulatory systems, and other enterprise applications. In addition, long-standing QMS platforms often include extensive custom configurations that are not pre-configured in new systems. Without a holistic view and proactive planning, the risk of disconnects, bottlenecks and conflicts increases substantially, resulting in loss of critical functionality or data.

Insufficient Stakeholder Engagement

Frequently system selection happens in an IT silo without involving user input resulting in low user adoption and solutions that don’t fit real-world processes. Even when the new system is objectively better, user resistance can undermine adoption if change management is not prioritized from the start.

fme’s Proven Strategies to Overcome QMS Challenges

Successful QMS/QDMS modernization requires more than technology decisions. It requires a strategic, structured approach that addresses business, technical, and human factors. Here are fme’s proven best practices we use to guide our clients’ journey:

Start with a Clear Assessment

Assess your current QMS/QDMS landscape–including pain points, compliance gaps, data quality, integration needs, user requests and future growth plans–to understand your current state. It’s vital to get a clear view of ACTUAL state of your environment and how it is truly used today. Too many companies rely on old documentation that is far from the reality of how business is done currently.

Engage Critical Stakeholders Early

Involve end-users, process owners, IT, and quality leaders in the selection process. This drives better fit, higher adoption, and ultimately a more successful implementation. Plan for seamless integration with ERP, MES, regulatory, and other critical systems. Address integration requirements early in both selection and implementation planning.

Prioritize Data, Metadata and Document Integrity

Don’t treat migration as a simple data transfer. Use it as an opportunity for data remediation, enrichment, and optimization to ensure your new system starts with clean, usable, compliant information. Also consider how your data may change in the future and plan flexibility to incorporate tomorrow’s requirements.

Structure the Selection Process

Use a structured methodology consistently across solution candidates. Include requirements gathering, vendor RFI, demo workshops, and technical validation to ensure you choose the solution that truly fits your unique needs.

Prepare for Change

Selecting a new solution is the beginning. Consider the crucial change management and user engagement tasks that will ensure your teams are ready to embrace the new system, not just tolerate it.

fme is Your Trusted Partner for QMS Modernization

With our proven SelectAssist℠ for Quality service, fme brings unparalleled expertise to help life sciences companies navigate QMS/QDMS modernization with confidence. Unlike general IT consultancies or software vendor professional services, fme provides you with:

  • 25 years of experience in industry leading platforms for quality, regulatory, and clinical solutions
  • Proven vendor-neutral selection methodology tailored to life sciences
  • Extensive experience with complex migrations, ensuring data integrity, compliance, and usability
  • Expertise in integration planning across the full enterprise landscape
  • Track record of enabling future-ready, scalable quality ecosystems — not just point solutions

Whether you are just beginning your assessment, actively selecting a new solution, or planning a complex migration, fme can serve as your strategic partner to guide the entire journey — from evaluation to execution.

fme is Ready to Help

Contact us today to learn how we can support your QMS/QDMS transformation — and help you choose the solution that’s aligned to your unique needs, both now and for the future. Download our SelectAssist for Quality datasheet below and request a meeting to get started today!